Teplizumab in Relatives at Risk for Type 1 Diabetes

N Engl J Med. 2019 Nov 7;381(19):1879. doi: 10.1056/NEJMc1912500.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Diabetes Mellitus, Type 1*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • teplizumab